Loomis Sayles & Co. L P lessened its position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,107,526 shares of the company’s stock after selling 19,119 shares during the quarter. Loomis Sayles & Co. L P owned approximately 1.28% of HealthEquity worth $106,267,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Wealthfront Advisers LLC purchased a new position in HealthEquity in the 4th quarter valued at approximately $10,304,089,000. Vanguard Group Inc. raised its stake in shares of HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock valued at $861,256,000 after acquiring an additional 99,624 shares in the last quarter. Wasatch Advisors LP boosted its holdings in HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares during the period. State Street Corp grew its stake in HealthEquity by 0.8% during the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after purchasing an additional 23,613 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in HealthEquity by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock worth $170,197,000 after purchasing an additional 15,145 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.
HealthEquity Stock Performance
Shares of HQY opened at $89.22 on Thursday. The firm has a market cap of $7.72 billion, a PE ratio of 81.85, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company’s 50 day simple moving average is $104.17 and its 200-day simple moving average is $95.89. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on HQY
Insider Activity
In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 2.20% of the company’s stock.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- Are Penny Stocks a Good Fit for Your Portfolio?
- Energy Transfer: Powering Data With Dividends and Diversification
- What is the S&P/TSX Index?
- Qualcomm Stock Is Coiling for a Breakout
- What is a Secondary Public Offering? What Investors Need to Know
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.